U.S. Infrastructure Stock News

NYSE:BANC
NYSE:BANCBanks

Higher Rates Put These Regional Bank Stocks In Focus

With the Federal Reserve holding interest rates at 3.5% to 3.75% and keeping borrowing costs elevated, the pressure on borrowers and the appeal of higher yields for savers are both in focus. That kind of backdrop can change how investors think about banks and savings institutions that depend on the spread between what they pay on deposits and earn on loans. This article focuses on financial stocks from our Banks & Savings Institutions screener that are particularly exposed to this rate...
NYSE:WBS
NYSE:WBSBanks

What Webster Financial (WBS)'s Marathon JV Non-Interest Income Plans Mean For Shareholders

Recently, Webster Financial came back into focus after analysts projected quarterly earnings of US$1.61 per share and higher year-over-year revenue, highlighting expectations for improved performance versus the prior period. A key angle is that Webster’s asset management joint venture with Marathon Asset Management is expected to materially boost non-interest income and broaden revenue sources starting in 2026. Now we’ll examine how the anticipated non-interest income boost from the Marathon...
NYSE:GPI
NYSE:GPISpecialty Retail

Group 1 Automotive (GPI) Could Be 22% Undervalued After Branding Push

Group 1 Automotive (GPI) is extending its unified branding push, with long-standing dealerships such as Group 1 Subaru Rivertown adopting the parent company name. Ownership, staffing, and daily operations remain unchanged for local customers. See our latest analysis for Group 1 Automotive. Recent branding updates at Group 1 Automotive sit against a mixed share price backdrop, with the stock rising 8.73% over the past week but down 16.94% year to date, while five year total shareholder return...
NasdaqCM:FBRX
NasdaqCM:FBRXBiotechs

Is Forte Biosciences (FBRX) Fully Valued Following Its Positive FB102 Vitiligo Data?

Forte Biosciences (FBRX) is back in focus after reporting statistically significant phase 1b data for FB102 in vitiligo, with early and sustained FVASI improvements and a safety profile that compared favorably to placebo. See our latest analysis for Forte Biosciences. Forte Biosciences has seen sharp positive momentum build around these FB102 results, with the 1 month share price return of 173.73% and year to date share price return of 106.95% contributing to a very large 1 year total...
NasdaqGS:CENX
NasdaqGS:CENXMetals and Mining

3 US Manufacturing Stocks Worth Watching As Brazil Tariffs Shift Demand

Tariffs between the US and Brazil are back in the headlines, and that kind of trade tension can quietly reshuffle the deck for large industrial and manufacturing stocks. Some companies face new questions around costs and supply chains, while others may find breathing room if Brazilian competitors become less price competitive. This article looks at three US industrial stocks from a health focused screener that appear closely exposed to the latest tariff news. You will see how each stock could...
NasdaqCM:CHRN
NasdaqCM:CHRNIT

ChronoScale Holdings (CHRN) Faces A Fresh Test After Shelf Filing As Valuation Stays Rich

ChronoScale Holdings shelf registration and ESOP related equity offering ChronoScale Holdings (CHRN) has filed a shelf registration for up to $452.016 million in equity shares, covering 25,800,000 securities tied to an Employee Stock Ownership Plan related offering. See our latest analysis for ChronoScale Holdings. ChronoScale Holdings has seen strong share price momentum alongside the shelf registration, with a 7 day share price return of 26.46%, a 90 day share price return of 132.25% and a...
NYSE:KO
NYSE:KOBeverage

Is Coca Cola (KO) Overvalued After The Fairlife Ransomware Disruption?

Why the Fairlife cyberattack has Coca-Cola (KO) back in focus Coca-Cola (KO) is under closer scrutiny after its Fairlife dairy subsidiary temporarily halted U.S. production following a ransomware attack affecting production related systems, raising fresh questions about operational resilience and cyber risk. See our latest analysis for Coca-Cola. Coca-Cola's share price fell 3.96% in the latest session to $81.56, yet a 30 day share price return of 2.73% and year to date gain of 18% suggest...
NYSE:ESNT
NYSE:ESNTDiversified Financial

Essent Group (ESNT) Could Be 3% Undervalued Ahead Of Its August Earnings Call

Essent Group (ESNT) has scheduled a conference call for August 7, 2026, to review its second quarter 2026 results, with earnings set for release before the market opens that day. See our latest analysis for Essent Group. Essent Group's share price has recently picked up, with a 30 day share price return of 14.13%, while its 1 year total shareholder return of 22.46% and 5 year total shareholder return of 69.13% point to building momentum around the stock. If this earnings update has you...
NasdaqGS:IART
NasdaqGS:IARTMedical Equipment

Integra LifeSciences Holdings (IART) Builds Ahead Of Results, Is The Stock Still 29% Undervalued?

Integra LifeSciences Holdings (IART) is back in focus as investors look ahead to its upcoming quarterly results, following a period of topping earnings expectations and receiving broadly favorable analyst commentary. See our latest analysis for Integra LifeSciences Holdings. The recent excitement around Integra LifeSciences Holdings sits against a sharp rebound in the stock, with a 90 day share price return of 72.49% and a year to date share price return of 60.28%. However, the 3 year and 5...
NasdaqGM:TRVI
NasdaqGM:TRVIPharmaceuticals

Trevi Therapeutics (TRVI) Is Up 6.9% After Haduvio Cough Data And New ILD Trial Plan - Has The Bull Case Changed?

Trevi Therapeutics recently reported that its oral extended-release nalbuphine candidate, Haduvio, produced a significant reduction in cough frequency in refractory chronic cough and idiopathic pulmonary fibrosis trials, and the company now plans to start a Phase 2b trial for non-IPF interstitial lung disease-related chronic cough in the second half of 2026. This progress highlights how a single late-stage asset is being positioned across several chronic cough populations where existing...
NYSE:KBR
NYSE:KBRProfessional Services

KBR (KBR) Joins Team ORION, Is The Stock 25% Below Fair Value?

KBR (KBR) is in focus after joining Unipart Group and IBM in Team ORION, a new alliance formed to support operational resilience, logistics and technology delivery for the UK Ministry of Defence. See our latest analysis for KBR. Despite KBR joining Team ORION and taking on specialist consulting work such as the recent hydrogen technology review, the stock has faced pressure. The share price is down 13.43% year to date and the 1 year total shareholder return has declined 23.44%, while multi...
NasdaqCM:WULF
NasdaqCM:WULFSoftware

Is TeraWulf (WULF) A Bargain As Its Anthropic Lease Reshapes Revenue Visibility?

TeraWulf (WULF) drew fresh attention after subsidiary Raylan Data LLC agreed to a 20-year Justified Data Campus Lease with Anthropic PBC, supporting approximately 401 MW of high-performance computing capacity in Hawesville, Kentucky. See our latest analysis for TeraWulf. The Anthropic agreement lands after a sharp pullback, with TeraWulf’s 30-day share price return down 37.34% and 7-day return down 17.34%, yet its year-to-date share price return of 42.54% and very large 1-year total...
NYSE:IOT
NYSE:IOTSoftware

Samsara Stock Leads 3 Fast Growing Tech Names Retail Investors Are Watching

Fast growing stocks with high insider ownership sit at the crossroads of improving sentiment and focused execution. This is why this screener can be useful when consumer confidence, inflation trends, and interest rate expectations are all in play. With analysts and company management sharing optimistic outlooks, investors are paying close attention to businesses where insiders have significant skin in the game and growth potential remains a key theme. This article highlights 3 stocks from the...
NYSE:BLDR
NYSE:BLDRBuilding

Builders FirstSource (BLDR) Could Be 24% Undervalued Following Earnings Fears

Builders FirstSource (BLDR) shares fell 5.04% to $74.26 after renewed concern around upcoming quarterly results, as analysts project a sharp drop in earnings and revenue, along with recent estimate cuts and rating downgrades. See our latest analysis for Builders FirstSource. The latest 1 day share price drop adds to a weak run for Builders FirstSource, with the stock down 7.85% on a 30 day share price basis and the 1 year total shareholder return down 39.7%. This may signal fading momentum as...
NasdaqGS:QRVO
NasdaqGS:QRVOSemiconductor

Should Qorvo’s Lifecycle-Focused Rochester Deal Require Action From Qorvo (QRVO) Investors?

On 14 July 2026, Rochester Electronics announced a worldwide distribution agreement with Qorvo, expanding access to Qorvo’s RF and power semiconductor solutions with a focus on long-term supply and lifecycle support. By partnering with a licensed manufacturer that specializes in continuing semiconductor supply, Qorvo is aiming to reduce redesign risk and extend the usable life of hardware platforms in sectors such as aerospace, defense, and communications. We’ll now examine how Qorvo’s...
NYSE:NCLH
NYSE:NCLHHospitality

Can Norwegian Cruise Line Holdings (NCLH) Justify Its Valuation As Adults Only Itineraries Roll Out?

Adults-only Caribbean itineraries reshape Norwegian Cruise Line Holdings focus Norwegian Cruise Line Holdings (NCLH) is drawing fresh attention after its Oceania Cruises brand introduced adults-only Caribbean itineraries, centered on curated cultural, culinary and shore experiences for travelers seeking more tailored voyages. This move extends the company’s focus on premium, experience-led cruising beyond its traditional family-oriented offerings. For investors, the shift raises questions...
NYSE:ELF
NYSE:ELFPersonal Products

Is e.l.f. Beauty (ELF) Fully Valued After The BAFTA Partnership And Gaming Grant?

e.l.f. Beauty (ELF) is back in focus after its e.l.f. Cosmetics brand partnered with BAFTA for the 2026 Student Awards, coinciding with a new US$15,000 grant aimed at emerging gaming talent. See our latest analysis for e.l.f. Beauty. At a share price of US$73.69, e.l.f. Beauty has seen a 14.78% 1 month share price return and a 7.70% 3 month share price return, even as the 1 year total shareholder return is down 37.35% and the 3 year total shareholder return is down 33.98%. This suggests short...
NasdaqGS:AMZN
NasdaqGS:AMZNMultiline Retail

Amazon.com (AMZN) Could Be 12% Undervalued Following Its $25.46b Bond Sale

Amazon.com (AMZN) has just completed a multi tranche bond sale of about US$25.46b, issuing a mix of fixed and floating rate senior unsecured notes maturing between 2029 and 2066 for general corporate purposes. See our latest analysis for Amazon.com. Amazon.com’s new bond issuance comes as the stock trades at US$247.23, with a 9.15% year to date share price return and a 3 year total shareholder return of 90.18%. This points to momentum that has built over the longer term more than in recent...
NYSE:EPAM
NYSE:EPAMIT

EPAM Systems (EPAM) Rebounds From A Sharp Reset, Is The Stock Cheap?

Recent Performance Snapshot for EPAM Systems Without a single clear catalyst driving headlines, EPAM Systems (EPAM) has still given investors plenty to assess, from near term share performance to the broader picture across the past year. The stock’s recent moves include a gain of about 1% over the past day, around 6% over the past week and roughly 16% over the past month, while the past 3 months show a decline of about 33%. See our latest analysis for EPAM Systems. Set against a year to date...
OTCPK:CPKF
OTCPK:CPKFBanks

Chesapeake Financial Shares (CPKF) Stock Faces Narrative Test As Net Margin Jumps To 27.4%

Chesapeake Financial Shares (CPKF) has just posted a punchy Q2 2026 update, with revenue of about US$26.4 million and basic EPS of US$1.75 alongside net income of roughly US$8.2 million. This puts fresh numbers behind the recent share price around US$37.78. Over the past few quarters the company has reported revenue of about US$19.3 million and EPS of US$0.67 in Q2 2025, US$21.7 million and US$1.37 in Q4 2025, and now US$26.4 million and US$1.75 in the current quarter. Over the same period,...
NYSE:WMS
NYSE:WMSBuilding

Advanced Drainage Systems (WMS) Held Its Annual Meeting, Is The Stock Still Cheap?

Advanced Drainage Systems (WMS) is back in focus after its 2026 virtual annual meeting, where shareholders elected nine directors, ratified Deloitte & Touche LLP as auditor, and backed a non-binding advisory vote on executive compensation. See our latest analysis for Advanced Drainage Systems. At a share price of $147.55, Advanced Drainage Systems has seen short term share price pressure, including a 1-day share price decline of 2.47% and a 90-day share price decline of 5.21%. The 1-year...
NYSE:DLB
NYSE:DLBSoftware

Dolby (DLB) Stock Looks Reasonable On Earnings While Returns Stay Weak

Dolby Laboratories stock has had a difficult run over the past few years, yet the current checks on its share price suggest the valuation still leans on the cheap side rather than fully pricing in that weaker track record. Over the past 5 years, Dolby Laboratories shareholders have seen the stock fall about 46%, which means the market has already reset expectations quite a bit. Future cash generation from Dolby Laboratories' licensing model may support the current share price, while any...
OTCPK:LKNC.Y
OTCPK:LKNC.YHospitality

Is Luckin Coffee (OTCPK:LKNC.Y) Below Fair Value After A 132% Run?

Luckin Coffee stock has delivered a strong 132.3% gain over the past 5 years, yet its current valuation checks still suggest the shares trade on the cheap side rather than looking stretched. Over 5 years, a 132.3% return indicates that early investors have already seen substantial value created, so the current price around this level needs to be weighed against what is already embedded in expectations. For a business built on scaling a physical retail network, the long term value case can...
NYSE:AUB
NYSE:AUBBanks

Higher Treasury Yields Are Changing The Case For Major US Bank Stocks

Surging 30 year Treasury and TIPS yields, a steeper curve and renewed inflation worries are reshaping the risk and reward trade off across major U.S. banks. Higher long term rates can pressure the value of older bonds on bank balance sheets, while also reshaping funding costs and lending margins. That mix creates both potential openings and pitfalls for investors trying to position around interest rate expectations. This article walks through 3 large, financially solid U.S. bank stocks from...